Study of Rule-Based Algorithms in Anemia Management in Prevalent Hemodialysis Patients and Its Relation to Patients' Outcomes

Ain Shams University

Status and phase: Active, not recruiting; Phase 1

Conditions: Anemia in End Stage Renal Disease

Treatments: Drug: ESA

Study type: Interventional

Funder types: Other

Identifiers

NCT06996717

MS 7/2024/2025

Details and patient eligibility

About

The study will assess role of rule based algorithm in anemia management in hemodialysis patients and its relation to patient's mortality

Enrollment: 145 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients on hemodialysis for more than six months patients undergoing hemodialysis three times per week each session for 4 hours patients with urea reduction ratio>65% patients with transferrin saturation>20%

Exclusion criteria

• patients with terminal illness or malignancy patients receiving hemodialysis from catheter or arteriovenous graft

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

145 participants in 1 patient group

end stage renal disease patients

Experimental group

Description:

management of different hemoglobin levels by erythropoietin stimulating agents according to expert opinion and according to algorithm

Treatment:

Drug: ESA